Hemosphere - About the company
Hemosphere is an acquired company based in Kennesaw (United States), founded in 1998. It operates as a Hemodialysis access solutions improving patient outcomes and reducing catheter dependency. Hemosphere has raised $9.3M in funding. The company has 40 active competitors, including 9 funded and 8 that have exited. Its top competitors include companies like Outset Medical, Quanta Dialysis Technologies and Diality.
Company Details
Hemodialysis access solutions improving patient outcomes and reducing catheter dependency. They specialize in innovative medical devices designed to improve hemodialysis access for patients with failing fistulas or grafts. Their flagship product offers a fully subcutaneous solution clinically proven to maintain long-term access, reduce infections, and improve dialysis adequacy. They provide comprehensive resources, including product finders, support videos, brochures, and educational materials for healthcare professionals. They are committed to advancing patient care through innovative medical technology and comprehensive support. Their solutions address critical needs in hemodialysis, offering alternatives to traditional catheters and improving the quality of life for patients.
- Website
- herograft.com
Key Metrics
Founded Year
1998
Location
Kennesaw, United States
Stage
Acquired
Total Funding
$9.3M in 1 round
Latest Funding Round
Investors
Ranked
11th among 40 active competitors
Employee Count
5 as on Jul 31, 2026
Similar Companies
Exit Details
Acquired by Merit (Feb 04, 2016)
Legal entities associated with Hemosphere
Hemosphere is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Hemosphere, Inc. CIN: 1487756 , United States, Active | $1M - $5M (As on Mar 23, 2010) | - | - |
Hemosphere's acquisition details
Click here to take a look at Hemosphere's acquisition in detail
Sign up to download Hemosphere's company profile
Hemosphere's funding and investors
Hemosphere has raised a total funding of $9.3M over 1 round. Its latest funding round was a Series A round on Mar 31, 2010 for $*****. 6 investors participated in its latest round. Hemosphere has 7 institutional investors.
Here is the list of recent funding rounds of Hemosphere:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 31, 2010 | 5899184 | Series A | 2327758 | 9242526 | 7773021 | 5564941 |
View details of Hemosphere's funding rounds and investors
Hemosphere's founders and board of directors
Founder? Claim ProfileHemosphere's employee count trend
Hemosphere has 5 employees as of Jul 26. Here is Hemosphere's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Hemosphere's Competitors and alternates
Top competitors of Hemosphere include Outset Medical, Quanta Dialysis Technologies and Diality. Here is the list of Top 10 competitors of Hemosphere, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Outset Medical 2003, San Jose (United States), Public | Provider of hemodialysis machine with touchscreen display | $458M | 64/100 | |
2nd | Quanta Dialysis Technologies 2008, Warwick (United Kingdom), Series E | Provider of a dialysis system offering multiple kidney therapy modalities | $433M | 60/100 | |
3rd | Diality 2013, Irvine (United States), Series C | Developer of portable hemodialysis device | $82.5M | - | 55/100 |
4th | Developer of renal care solutions including dialysis and CKD detection | $1.25M | 55/100 | ||
5th | Manufacturer of a hemodialysis monitoring device | $15.9M | 53/100 | ||
6th | Avenu Medical 2010, Dana Point (United States), Acquired | An image-guided catheter system used to percutaneously create an arteriovenous (AV) fistula | $36M | - | 41/100 |
7th | NxStage 1998, Lawrence (United States), Acquired | Home dialysis therapies and systems for kidney disease patients | - | 39/100 | |
8th | Manufacturer of renal care products | $4M | 37/100 | ||
9th | NextKidney 2020, Lausanne (Switzerland), Series B | Developer of portable home hemodialysis devices for kidney disease patients | $20M | 37/100 | |
10th | NovaFlux Technologies 1988, Princeton (United States), Funding Raised | Innovating healthcare through advanced medical device technologies and infection control | - | 33/100 | |
11th | Hemosphere 1998, Kennesaw (United States), Acquired | Hemodialysis access solutions improving patient outcomes and reducing catheter dependency | $9.3M | 33/100 |
Looking for more details on Hemosphere's competitors? Click here to see the top ones
Hemosphere's Investments and acquisitions
Hemosphere has made no investments or acquisitions yet.
Reports related to Hemosphere
Here is the latest report on Hemosphere's sector:
News related to Hemosphere
•
•
Reuters•Hemosphere, Kaiser Permanente Ventures, Mutual Capital Partners, Affinity Capital Management and 3 others
Are you a Founder ?
FAQs about Hemosphere
Explore our recently published companies
- Captain - Montreal based, 2021 founded, Unfunded company
- Navigo - Delhi based, 2024 founded, Unfunded company
- Skynext - Mumbai based, 2020 founded, Unfunded company
- Digital Maker - Peterhead based, 2017 founded, Unfunded company
- Byteport - San Francisco based, 1999 founded, Seed company
- Back Benchers - India based, 2024 founded, Unfunded company